The Global Dermatology Market 2013-2023

Product code:GDS1

Availability: In stock

€2,499.00

Qty: Buy Now - OR -

 

 

170 Pages

160 Tables & Figures

3 Exclusive Interviews

 

 

The Global Dermatology Market 2013-2023 covers the Pharmaceutical, Commercial, & Strategic Developments in Global Dermatology across the next decade. The report analyses how this important pharma sector will develop over the next ten years.


The report quantifies the market in terms of global size and breaks the market down into key leading countries with forecasts and analysis provided for each of these markets from 2013-2023. The report also examines the major drivers and restraints influencing the market over the next decade and explains the pharmaceutical developments within the market, analysing which companies will drive R&D in the Dermatology sectors.

 

GMR Data’s The Global Dermatology Market 2013-2023 report details the prospects for this dynamic pharmaceutical sector with detailed forecasts from 2013-2023. The report will be valuable to those already involved in the dermatology market or to those wishing to enter this important market in the future.

 

The Global Dermatology Market 2013-2023 report includes 170 pages, which include over 160 tables, charts and graphs quantifying and forecasting the market in detail. In addition, the report offers profiles of the 13 leading companies in the dermatology market, alongside 3 interviews with;

  • Cutting edge R&D company;  KLOX Technologies Inc of Canada
  • Highly experienced dermatology doctor; Dr Keong of Garden Clinic Haroo, Tokyo
  • And the world’s largest rosacea forum; the Global Rosacea Forum.

 

These 3 interviews offer an expert insight into the direction of the dermatology sector, across the next decade, which underpins the detailed analysis and forecast areas.

 

 

Download the free dermatology market report sample today. For any further questions regarding this, or any other GMR Data report, please contact +353 86 075 2687 or alice.morgan@gmrdata.com

Chapter 1 Executive Summary

 

1.1.              Dermatological Drugs Market Review

1.2.             Chapter Breakdown

1.3.             Research and Analysis Methods

 

Chapter 2 Introduction to Dermatological Diseases and Treatments

 

2.1           Structure and Function of Human Skin

2.2           Dermatological Conditions & Skin disorders

2.2.1        Acne (Acne Vulgaris)

2.2.1.1     Types & Symptoms of Acne

2.2.1.2     Current Treatments for Acne

2.2.2        Dermatitis

2.2.2.1     Types & Symptoms of Dermatitis

2.2.2.2     Current Treatments for Dermatitis

2.2.3        Psoriasis

2.2.3.1     Types & Symptoms of Psoriasis

2.2.3.2     Current Treatments for Psoriasis

2.2.4        Skin Cancer

2.2.4.1      Types & Symptoms of Skin Cancer

2.2.4.2      Current Treatments for Skin Cancer

2.2.5        Skin Infections

2.2.5.1     Types & Symptoms of Skin Infections

2.2.5.2     Current Treatments for Skin Infections

2.2.6        Rosacea

2.2.6.1     Types & Symptoms of Rosacea

2.2.6.2     Current Treatments for Rosacea

2.2.7        Alopecia

2.2.7.1     Types & Symptoms of Alopecia

2.2.7.2      Current Treatments for Alopecia

 

Chapter 3 Current Trends & Developments in the Dermatology Market 2013-2023

 

3.1            Current Trends & Development

3.2            Major Players – Landscape

 

Chapter 4 Dermatological Drugs Market & Forecast

              

4.1 Global Acne Market – 2013 -2023

4.1.1   Major Trends & Issues

4.1.2   Market Size & Forecast

4.1.3   Major Drugs & Forecast

4.1.4   New Developments

4.1.5   Future Pipeline Analysis

4.1.6   The World Acne Drug Market – Summary

4.2      Global Psoriasis Market – 2013 -2023

4.2.1    Major Trends & Issues

4.2.2    Market Size & Forecast

4.2.3    Biologics

4.2.4    Future Pipeline Analysis

4.2.5    The World Psoriasis Drug Market – Summary

4.3       Global Atopic Dermatitis Market – 2013 -202

4.3.1     Major Trends & Issues

4.3.2        Market Size & Forecast

4.3.3        Biologics

4.3.4       Future Pipeline Analysis

4.3.5        The World Atopic Dermatitis Drug Market – Summary

4.4     Global Skin Cancer Market – 2013 -2023

4.4.1        Major Trends & Issues

4.4.2       Market Size & Forecast

4.4.3       Major Drugs & Forecast

4.4.4       New Product Pipeline

4.4.5       The World Skin Cancer Drug Market – Summary

4.5     Global Skin Infections Market – 2013 -2023

4.5.1         Major Trends & Issues

4.5.2        Market Size & Forecast

4.5.3        Major Drugs & Forecast

4.5.4       New Product Pipeline

4.6     Global Rosacea Market – 2013 -2023

4.6.1        Major Trends & Issues

4.6.2       Market Size & Forecast

4.6.3       Major Drugs

4.6.4       New Product Pipeline

4.7     Global Alopecia Market – 2013 -2023

4.7.1         Major Trends & Issues

4.7.2        Market Size & Forecast

4.7.3        Biologics

4.7.4       Future Drug Pipeline Analysis

4.7.5        The World Alopecia Drug Market – Summary

 

5 Leading Companies in the Global Dermatological Market

5.1 Allergan, Inc

5.2 Bayer AG

5.3 Galderma

5.4 Valeant Pharmaceuticals International, Inc

5.5 Stiefel Laboratories, Inc

5.6 Novartis, Inc

5.7 Almirall, S.A

5.8 Derma Sciences

5.9 Hill Dermaceuticals, Inc

5.10 Biofrontera AG

5.11 Merck & Co. Inc

5.12 Merz Pharma Group

5.13 Laboratories Pierre Fabre

 

 6 Key National Markets in the Global Dermatology Sector 2013-2023

6 Global Outlook 2013-2023

6.2 The US Dermatology Market 2013-2023

6.3 The UK Dermatology Market 2013-2023

6.4 The French Dermatology Market 2013-2023

6.5 The German Dermatology Market 2013-2023

6.6 The Spanish Dermatology Market 2013-2023

6.7 The Italian Dermatology Market 2013-2023

6.8 The Japanese Dermatology Market 2013-2023

6.9 The Rest of the World Dermatology Market 2013-2023

 

7 Expert Opinion

7.1 Klox Technologies Inc.

7.2 Global Rosacea Forum

7.3 Dr. Chin-Huai Keong

 

List of Tables

Table 2.2.1 Acne Type & Symptoms

Table 2.2.2 Dermatitis Types & Symptoms

Table 2.2.2.1.a Major drugs for Dermatitis in the Market

Table 2.2.2.2.a Dermatitis Drug Pipeline

Table 2.2.3.1 Psoriasis Types & Symptoms

Table2.2.3.1.a Prevalence of Psoriasis in Selected Countries Worldwide 2013

Table 2.2.3.3.a Psoriasis Phase 3 Drugs Pipeline

Table 2.2.3.3.b Psoriasis Phase 2 Drugs Pipeline

Table 2.2.4 Skin Cancer Types & Symptoms

Table 2.2.4.1 Skin Cancer Types & Symptoms

Table 2.2.4.3 Skin Cancer Types & Symptoms

Table 2.2.5.a Bacterial Infection Types & Symptoms

Table 2.2.5.b Viral Infection Types & Symptoms

Table 2.2.5.c Fungal Infection Types & Symptoms

Table 2.2.5.d Parasitic Infection Types & Symptoms

Table 2.2.5.1 Major Drugs for Skin Infection in the Market

Table 2.2.5.3 Skin Infection Drug Pipeline

Table 2.2.6.1 Skin Infection Drug Pipeline

Table 2.2.7: Alopecia Types & Symptoms

Table 2.2.7.1 Major Drugs for Alopecia

Table 2.2.7.2 Alopecia Drugs Pipeline

Table 3.2.1 Merger & Acquisitions

Table 4.a Market Size & Forecast – Global Dermatological Drugs

Table 4.b Global Dermatological Drug Market Forecast ($/bn, P/A, CAGR)

Table 4.1.2.a Market Size & Forecast – Acne Market ($/m, P/A, CAGR)

Table 4.1.2.b Acne Drugs Market Share – By Revenue ($/bn, P/A, CAGR)

Table 4.1.3.1 Market Forecast for Solodyn ($/m, P/A, CAGR)

Table 4.1.3.2 Market Forecast for Isotretinoin ($/m, P/A, CAGR)

Table 4.1.3.3 Market Forecast for Doryx ($/m, P/A, CAGR)

Table 4.1.3.4 Market Forecast for Diane ($/m, P/A, CAGR)

Table 4.1.3.5 Market Forecast for Ziana ($/m, P/A, CAGR)

Table 4.1.4.1 Acne Drugs R&D Pipeline 2013

Table 4.2.2.a Market Size & Forecast – Psoriasis Market ($/m, P/A, CAGR)

Table 4.2.3.1 Total Enbrel Sales 2010, 2011 & 2012 ($/m, CAGR)

Table 4.2.3.2 Enbrel Forecasting for Psoriatic Treatment ($/m, P/A, CAGR)

Table 4.2.3.3 Total Humira Sales 2010, 2011 & 2012 ($/m, CAGR)

Table 4.2.3.4 Humira Forecasting for Psoriatic Treatment ($/m, P/A, CAGR)

Table 4.2.3.5 Total Remicade Sales 2010, 2011 & 2012 ($/m, CAGR)

Table 4.2.3.5 Total Stelara Sales 2010, 2011 & 2012 ($/m, CAGR)

Table 4.2.3.6 Total Simponi Sales 2010, 2011 & 2012 ($/m, CAGR)

Table 4.3.2.1 Market Size & Forecast for Atopic Dermatitis ($/m, P/A, CAGR)

Table 4.3.3.1 Revenue of Protopic ($/m, P/A, CAGR)

Table 4.3.3.2 Market Size & Forecast for Protopic ($/m, P/A, CAGR)

Table 4.4.2.4 Revenue for Elidel ($/m, P/A, CAGR)

Table 4.3.3.3 Market Size & Forecast for Elidel ($/m, P/A, CAGR)

Table 4.3.3.4 Revenue for Clobex ($/m, P/A, CAGR)

Table 4.3.3.5 Market Size & Forecast for Clobex ($/m, P/A, CAGR)

Table 4.3.3.6 Revenue for Elocon ($/m, P/A, CAGR)

Table 4.3.3.7 Market Size & Forecast for Elocon ($/m, P/A, CAGR)

Table 4.4.2.1 Market Size & Forecast for Melanoma Skin Cancer ($/bn, P/A, CAGR)

Table 4.4.2.2 Revenue of Yervoy ($/m, P/A, CAGR)

Table 4.4.2.3 Market Size & Forecast for Yervoy ($/m, P/A, CAGR)

Table 4.4.2.4 Revenue of Zelboraf ($/m, P/A, CAGR)

Table 4.4.2.5 Market Size & Forecast for Zelboraf ($/m, P/A, CAGR)

Table 4.5.2.1 Market Size & Forecast for Skin and Skin Structure Infections ($/bn, P/A, CAGR)

Table 4.5.2.2 Market Size & Forecast for Herpes ($/bn, P/A, CAGR)

Table 4.5.3.1 Revenue of Zyvox ($/m, P/A, CAGR)

Table 4.5.3.2 Market Size & Forecast for Zyvox ($/m, P/A, CAGR)

Table 4.5.3.3 Revenue for Cubicin ($/m, P/A, CAGR)

Table 4.5.3.4 Market Size & Forecast for Cubicin ($/m, P/A, CAGR)

Table 4.5.3.5 Revenue for Zovirax ($/m, P/A, CAGR)

Table 4.5.3.6 Market Size & Forecast for Zovirax ($/m, P/A, CAGR)

Table 4.5.3.7 Revenue for Valtrex ($/m, P/A, CAGR)

Table 4.5.3.8 Market Size & Forecast for Valtrex ($/m, P/A, CAGR)

Table 4.5.3.9 Revenue for Zostavax ($/m, P/A, CAGR)

Table 4.5.3.10 Market Size & Forecast for Zostavax ($/m, P/A, CAGR)

Table 4.6.2.1 Market Size & Forecast – Rosacea Market ($/bn, P/A, CAGR)

Table 4.6.3.1 Major Drugs – Rosacea Market ($/bn, P/A, CAGR)

Table 4.6.3.2 Oracea Forecasting for Rosacea Treatment ($/m, P/A, CAGR)

Table 4.6.4.1 New Product Pipeline for Rosacea Treatment

Table 4.7.2.1 Market Size & Forecast for Alopecia ($/bn P/A, CAGR)

Table 4.7.3.1 Revenue of Propecia ($/m, P/A, CAGR)

Table 4.7.3.2 Market Size & Forecast for Propecia ($/m, P/A, CAGR)

Table 4.7.3.3 Market Size & Forecast for Rogaine ($/m, P/A, CAGR)

Table 5.1.1 Allergan Products Overview

Table 5.1.2 Allergan R&D Pipeline in the Dermatology Segment – 2012

Table 5.2.1 Bayer’s Key Dermatology Products 2013

Table 5.2.2 Bayer’s R&D Pipeline - 2013

Table 5.3.1 Galderma Key Dermatology Products 2013

Table 5.4.1 Valeant Key Dermatology Products 2013

Table 5.4.2 Valeant’s R&D Pipeline

Table 5.5.1 Stiefel’s Products Overview 2013

Table 5.5.2 Stiefel R&D Pipeline in the Dermatology Segment - 2013

Table 5.6.1 Novartis (Fougera) Products Overview

Table 5.6.2 Novartis R&D Pipeline in the Dermatology Segment - 2013

Table 5.7.1 Almirall Products Overview

Table 5.7.2 Almirall R&D Pipeline in the Dermatology Segment - 2013

Table 5.9.1 Hill Products Overview

Table 5.10.1 Biofrontera Product Overview

Table 5.10.2 Biofrontera Drug Pipeline

Table 5.11.1 Merck & Co, Inc Product Overview

Table 5.11.2 Merck & Co, Inc Drug Pipeline

Table 5.12.1 Merz Product Overview

Table 5.13.1 Pierre Fabre Product Overview

Table 6.0.1 The Global Dermatology Market Forecast 2011 -2023, by Country ($/bn, P/A, CAGR)

Table 6.0.2 Key Countries CAGR 2013-2023 (%)

Table 6.0.3 Estimated Dermatological Market Share for Selected Countries 2013, 2018 and 2023 (%)

Table 6.0.7 Total Healthcare Expenditure per Capita 2011, Sample countries ($/p/a)

Table 6.1.1 The US Dermatology Market Forecast 2011-2023 ($/bn, P/A, CAGR, %)

Table 6.2.1 The UK Dermatology Market Forecast 2011-2023 ($/bn, P/A, CAGR, %)

Table 6.3.1 The French Dermatology Market Forecast 2011-2023 ($/bn, P/A, CAGR, %)

Table 6.4.1 The German Dermatology Market Forecast 2011-2023 ($/bn, P/A, CAGR, %)

Table 6.5.1 The Spanish Dermatology Market Forecast 2011-2023 ($/bn, P/A, CAGR, %)

Table 6.6.1 The Italian Dermatology Market Forecast 2011-2023 ($/bn, P/A, CAGR, %)

Table 6.7.1 The Japanese Dermatology Market Forecast 2011-2023 ($/bn, P/A, CAGR, %)

Table 6.8.1 The ROW Dermatology Market Forecast 2011-2023 ($/bn, P/A, CAGR, %)

Table 6.8.3 BRIC Population, GDP 2000 & 2010, CAGR & GDP per Capita 2000 & 2010 ($)

Table 6.8.4 Galderma & Novartis Global HQ, R&D and Manufacturing Sites

 

List of Figures

Figure 2.2.3.1 Breakdown by Type , Psoriasis

Figure 2.2.4.1 Global Market Size as per Skin Cancer Type – Incidences

Figure 4.a Global Dermatological Drug Market Growth

Figure 4.b Global Dermatological Drug Market Share – By Revenue

Figure 4.1.2.a Acne Market Growth

Figure 4.1.2.b. Acne Drugs Market Share – By Revenue

Figure 4.1.3.1 Solodyn Market Growth

Figure 4.1.3.2 Isotretinoin Market Growth

Figure 4.1.3.3 Doryx Market Growth

Figure 4.1.3.4 Diane Market Growth

Figure 4.1.3.5 Ziana Market Growth

Figure 4.2.2.a Psoriasis Market Growth

Figure 4.2.2.b Overall Psoriatic therapeutic market - Growth from 2012 to 2013

Figure 4.2.3.1 Enbrel Market Growth

Figure 4.2.3.2 Humira Market Growth

Figure 4.3.2.1 Atopic Dermatitis Market Growth

Figure 4.3.3.1 Protopic Market Value

Figure 4.3.3.2 Elidel Market Growth

Figure 4.3.3.3 Clobex Market Growth

Figure 4.3.3.4 Elocon Market Growth

Figure 4.4.2.1 Melanoma Skin Cancer Market Growth

Figure 4.4.2.2 Yervoy Market Growth

Figure 4.4.2.3 Zelboraf Market Growth

Figure 4.5.2.1 Skin & Skin Structure Infections Market

Figure 4.5.2.2 Herpes Market

Figure 4.5.3.1 Zyvox Market Growth

Figure 4.5.3.2 Cubicin Market Growth

Figure 4.5.3.3 Zovirax Market Growth

Figure 4.5.3.4 Valtrex Market Growth

Figure 4.5.3.5 Zostavax Market Growth

Figure 4.6.2.a Zostavax Market Growth

Figure 4.6.3.1 Rosacea Market Growth

Figure 4.6.3.2 Oracea Market Growth

Figure 4.7.2.1 Alopecia Market Growth

Figure 4.7.3.1 Propecia Market Growth

Figure 4.7.3.2 Rogaine Market Growth

Figure 6.0.4 Global Market Share for Selected Countries 2013

Figure 6.0.5 Global Market Share for Selected Countries 2018

Figure 6.o.6 Global Market Share for Selected Countries 2023

Figure 6.1.2 The US Dermatology Market Forecast 2011-2023 ($/bn)

Figure 6.2.2 The UK Dermatology Market Forecast Figure 2011-2023 ($/bn)

Figure 6.3.2 The French Dermatology Market Forecast 2011-2023 ($/bn)

Figure 6.4.2 The German Dermatology Market Forecast 2011-2023 ($/bn)

Figure 6.5.2 The Spanish Dermatology Market Forecast 2011-2023 ($/bn)

Figure 6.6.2 The Italian Dermatology Market Forecast 2011-2023 ($/bn)

Figure 6.7.2 The Japanese Dermatology Market Forecast 2011-2023 ($/bn)

Table 6.8.2 The ROW Dermatology Market Forecast 2011-2023 ($/bn)

 

 

 

Companies mentioned in this report;

AAIPharma Services

Abbott

AbbVie  Inc

Actavis

Actelion

Aderans Research Institute

Alcon

Allergan, Inc

Almirall, S.A

Amgen

Anacor Pharmaceutical

Anacor Pharmaceuticals

AndroScience Corporation

ApoPharma

Array Biopharma

Ascent Pharmahealth

Aspen Pharmacare

Astellas Pharma

AstraZeneca

AstraZeneca

BASF Pharma

Basilea Pharmaceutica Ltd

Bayer AG

BioForm Medical, Inc

Biofrontera AG

Biofrontera Bioscience GmbH

Biofrontera Pharma GmbH

BioMAS Ltd.

Biotest

Biovail Corporation

Bipharma

BMS

Bristol-Myers Squibb

Can-Fite BioPharma

Celegene Corporation

Cobrek Pharmaceuticals

CollaGenex Pharmaceuticals

Coria Laboratories, Ltd

Cosmo Pharama

Cosmo Pharmaceuticals

Creabilis Therapeutics

Cubist

Cutanea Life sciences

Derma Sciences, Inc

Dermik

Dow Pharmaceutical

DUSA Pharmaceuticals

Eisai Ltd.

Eli Lily

Elorac

EMO-FARM Ltd

Excaliard Pharmaceuticals

Forest Laboratories

Forward-Pharma GmbH

Fougera Pharmaceuticals

Furiex Pharmaceuticals

Galderma

Genzyme

GlaxoSmithKline

Glenmark

Graceway Pharmaceuticals

Helix Biomedix

Heritage Pharmaceuticals

Hill Dermaceuticals, Inc

Hygeia Therapeutics

Hygeia Therapeutics

Immunotech

Impax

Incyte

Intendis

Intendis GmbH

Ipsen

Isotecknika

Italfarmaco

Janssen Biotech

Johnson & Johnson

Kuhnil Pharmaceutical

Laboratoires Roche

Leo Pharma

L'Oréal

Lundbeck

Maruho

Maruho Co. Ltd.

McNeil-PPC

Meda AB

Medarex

MedEfficiency

Medicis

Merck & Co. Inc

Merz Pharma Group

Morria

Mylan

Mylan Inc

Nabriva Therapeutics

Nektar

Nestlé

Novartis, Inc

Obagi

Ortho Dermatologics

Ortho Dermatologics

Paddock

Paddock Laboratories

Paratek Pharmaceuticals

Pelpharma

Perigo

Perrigo

Pfizer

PHA Farmed s.p.

Pharma.MT Ltd

Pharmacenter

Pierre Fabre

PreCision Dermatology

Provectus Pharmaceuticals

Q-Med

Ranbaxy

Rib-X Pharmaceuticals

R-Tech Ueno Ltd

Sandoz

Sanofi

Sanofi Aventis

Schering AG

Schering-Plough

SkinMedica, Inc

Spirig Pharma

Stiefel Laboratories, Inc

Sun Pharmaceutical

Takeda

Targanta Therapeutics

TaroPharma

Tetraphase Pharmaceuticals

The Medicine Company

Theravance

Triax Pharmaceuticals

Trius Therapeutics

Trius Therapeutics, Inc

UCB Inc

University Hospital of Bordeaux

Upjohn

Valeant Pharmaceuticals International, Inc

VBL Therapeutics

Vicept Therapeutics

Warner Chilcott

Watson Pharma Inc

Welichem Biotech

Welichem Biotech Inc.

Wellspring Pharmaceuticals

York Pharma